| __timestamp | Catalyst Pharmaceuticals, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 4042025 |
| Thursday, January 1, 2015 | 8597010 | 5279557 |
| Friday, January 1, 2016 | 7910260 | 8073913 |
| Sunday, January 1, 2017 | 7304399 | 44864073 |
| Monday, January 1, 2018 | 15875961 | 53488904 |
| Tuesday, January 1, 2019 | 36881187 | 65896361 |
| Wednesday, January 1, 2020 | 44233754 | 69968267 |
| Friday, January 1, 2021 | 49628000 | 92047281 |
| Saturday, January 1, 2022 | 58183000 | 131819000 |
| Sunday, January 1, 2023 | 133710000 | 87501000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: Pharming Group N.V. and Catalyst Pharmaceuticals, Inc., from 2014 to 2023.
Catalyst Pharmaceuticals, Inc. has shown a remarkable increase in SG&A expenses, growing by approximately 2,900% over the decade. This surge, peaking in 2023, reflects their aggressive expansion and marketing strategies. In contrast, Pharming Group N.V. experienced a more moderate increase of around 2,100%, with a significant spike in 2022.
These trends highlight differing strategic priorities. Catalyst's rapid expense growth suggests a focus on market penetration, while Pharming's steadier increase may indicate a balanced approach to growth and cost management. Investors and stakeholders should consider these financial trajectories when evaluating future prospects.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Pharming Group N.V.
Comparing SG&A Expenses: Viatris Inc. vs Pharming Group N.V. Trends and Insights
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Pharming Group N.V.
Sarepta Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Blueprint Medicines Corporation vs Pharming Group N.V. Trends and Insights
Cost Management Insights: SG&A Expenses for Pharming Group N.V. and Corcept Therapeutics Incorporated
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: Pharming Group N.V. vs Xenon Pharmaceuticals Inc. Trends and Insights
Pharming Group N.V. vs HUTCHMED (China) Limited: SG&A Expense Trends
Xenon Pharmaceuticals Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Xencor, Inc. Trends and Insights